Abstract: One aspect of the present disclosure is a pharmaceutical composition which includes (R)—N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide as a first component and a cellulosic polymer as a second component, wherein the composition of one aspect of the present disclosure has a formulation characteristic in which crystal formation is delayed for a long time.

Abstract: The present invention relates to a variable resistor comprises a first electrode, a second electrode, and a resistive switching layer disposed between the first electrode and the second electrode, wherein the resistive switching layer has a Brown-Millerite structure crystallized in an inclined orientation across the first electrode and the second electrode as an initial structure.

Abstract: Disclosed in the present specification is a method capable of preparing N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide (INT028-2) with high optical purity, through the selection of Ellman-chiral auxiliaries and the recrystallization and separation of optical isomers. According to the above method, high-purity N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide with excellent quality can be produced at room temperature by improving cryogenic process conditions necessary for realizing high optical purity, and thus the trimming due to the process failure rate can be remarkably reduced.

Abstract: The present invention relates to a positive electrode active material for a lithium secondary battery, which includes two types of layered structure materials and may improve properties by controlling an optimum cation (lithium and transition metals) distribution capable of increasing activity of oxygen ions, as anions, in the layered structure materials, and a method of preparing the same.

Abstract: One aspect of the present disclosure is a pharmaceutical composition which includes (R)—N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide as a first component and a cellulosic polymer as a second component, wherein the composition of one aspect of the present disclosure has a formulation characteristic in which crystal formation is delayed for a long time.

Abstract: A method for forming a conductive metal-polymer composite coated polymer includes providing a polymer substrate and immersing the polymer substrate in a metal solution. The method further includes decomposing the metal solution in a thermally controlled environment and reducing the metal solution to metal such that the metal is deposited on a surface of the polymer substrate. After reducing the metal solution, the method includes treating the surface with a polymer coating to form the metal-polymer composite coated polymer.

Abstract: Disclosed in the present specification is a method capable of preparing N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide (INT028-2) with high optical purity, through the selection of Ellman-chiral auxiliaries and the re-crystallization and separation of optical isomers. According to the above method, high-purity N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide with excellent quality can be produced at room temperature by improving cryogenic process conditions necessary for realizing high optical purity, and thus the trimming due to the process failure rate can be remarkably reduced.

Abstract: The present specification relates to a chiral resolution method of a stereoisomer mixture, comprising a step of mixing a stereoisomer mixture of compounds, in which an amine group is bound to an asymmetric carbon atom, with a chiral auxiliary and salt-forming auxiliary compound, wherein the chiral auxiliary is an O,O?-diacyltartaric acid derivative, more specifically, a 2,3-dibenzoyl-tartaric acid or O,O?-di-p-toluoyl tartaric acid, the salt-forming auxiliary compound is mandelic acid or camphorsulfonic acid, and an optical isomer having a high level of optical purity can be obtained by using the method. Therefore, according to one aspect of the present invention, the method can be useful in pharmaceutical or cosmetic field when preparing an optical isomer having a high optical purity.

Abstract: The present invention relates to a variable resistor comprises a first electrode, a second electrode, and a resistive switching layer disposed between the first electrode and the second electrode, wherein the resistive switching layer has a Brown-Millerite structure crystallized in an inclined orientation across the first electrode and the second electrode as an initial structure.

Abstract: A backlight unit comprises a plurality of point light sources facing a rear surface of a liquid crystal panel; a bottom cover comprising a lower surface supporting the plurality of point light sources and two or more side surfaces disposed between the lower surface of the bottom cover and the liquid crystal panel; and a support side in contact with a first side surface of the bottom cover's side surfaces and in contact with the lower surface of the bottom cover in order to change a path of light from the plurality of point light sources toward the liquid crystal panel, the support side including a plurality of support side members oriented at different angles relative to the bottom cover.

Abstract: In various embodiments, the present application provides electrically conductive metal-plated fibers and continuous processes of preparing metal-plated fibers. Additionally, provided are polymeric articles comprising the provided metal-plated fibers or other fibers prepared by the provided process, said articles having electromagnetic interference shielding effectiveness.

Abstract: Disclosed are clothes for providing a display function. The clothes may include: a flexible display module including a predetermined number of light emitting diode elements disposed at a predetermined interval; a communication module which communicates with at least one of a user terminal and a control server, and receives at least one of a control signal and image data, the image data including at least one of still image data and video data; a control module which controls the flexible display module to output an image corresponding to h received image data in response to the received control signal or a control signal generated by the control module; and a memory module which stores at least one of an image that is displayable in the flexible display module and identification information of the clothes.

Abstract: The present specification relates to a chiral resolution method of a stereoisomer mixture, comprising a step of mixing a stereoisomer mixture of compounds, in which an amine group is bound to an asymmetric carbon atom, with a chiral auxiliary and salt-forming auxiliary compound, wherein the chiral auxiliary is an O,O?-diacyltartaric acid derivative, more specifically, a 2,3-dibenzoyl-tartaric acid or O,O?-di-p-toluoyl tartaric acid, the salt-forming auxiliary compound is mandelic acid or camphorsulfonic acid, and an optical isomer having a high level of optical purity can be obtained by using the method. Therefore, according to one aspect of the present invention, the method can be useful in pharmaceutical or cosmetic field when preparing an optical isomer having a high optical purity.

Abstract: A backlight unit comprises a plurality of point light sources facing a rear surface of a liquid crystal panel; a bottom cover comprising a lower surface supporting the plurality of point light sources and two or more side surfaces disposed between the lower surface of the bottom cover and the liquid crystal panel; and a support side in contact with a first side surface of the bottom cover's side surfaces and in contact with the lower surface of the bottom cover in order to change a path of light from the plurality of point light sources toward the liquid crystal panel, the support side including a plurality of support side members oriented at different angles relative to the bottom cover.

Abstract: A leg locking device for a tripod including a buckle base that telescopes a leg, a buckle, and a steel belt, the buckle including a cam and a pinch plate, the cam is, through a shaft, connected to one end of the buckle base, one end of the pinch plate is fixed on the cam, and the other end of the pinch plate bends into an arc inward along the buckle base, and the steel belt rounds the cam and is fixed at the other end of the buckle base reversely with the pinch plate. By cam rotation, the cam gradually increases the pulling force on the steel belt during rotation, so that the buckle base is deformed and compressed on the leg. The pinch plate can be pressed onto the buckle base under the reaction force of the steel belt, so that the leg is rapidly locked.

Abstract: A central post reversion device for a tripod, including an upper protective cap, a lower protective cap, a left spherical shell and a right spherical shell and a central post finger used to telescope the central post, the upper protective cap is fixed on the lower protective cap to form, with the lower protective cap, a spherical receiving cavity with opening, the left spherical shell and the right spherical shell are placed into the spherical receiving cavity symmetrically, the central post finger is placed between and fixed by the left spherical shell and the right spherical shell.

Abstract: Conductive metal and metallized fiber hybrid wires are disclosed, wherein such wires have a central member and a peripheral member and comprise at least one conductive metallized fiber. The peripheral member comprises (i) at least one conductive metal filament; and (ii) optionally, at least one conductive metallized fiber. The central member comprises (i) at least one non-metallized fiber; (ii) at least one conductive metallized fiber; (iii) at least one conductive metal filament; or (iv) combinations thereof.

Abstract: The use of sterculic acid, and the pharmaceutically acceptable salt forms thereof, described for the treatment of inflammation, in particular, 7-ketocholesterol induced inflammation, 7-ketocholesterol toxicity, and unregulated angiogenesis.

Abstract: Provided is an apparatus for analyzing an electroluminescence sample, which comprises: a pulse generator for applying a pulse driving signal to the electroluminescence sample; an electroluminescence (EL) detector for receiving electroluminescence which is emitted from the electroluminescence sample according to the application of the pulse driving signal, thereby acquiring a light-receiving signal; a temperature controller for varying the temperature of the electroluminescence sample; and an electroluminescence transient spectroscopy (ELTS) analysis unit for analyzing a change in a time division section of the light-receiving signal delayed depending on a change of the temperature of the electroluminescence sample, and acquiring information on a defect-type charge trap which exists in the electroluminescence sample.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.